Article thumbnail

Endocytosis and Sphingolipid Scavenging in Leishmania mexicana Amastigotes

By Hayder Z. Ali, Clare R. Harding and Paul W. Denny

Abstract

Leishmania species are the causative agents of the leishmaniases, a spectrum of neglected tropical diseases. Amastigote stage parasites exist within macrophages and scavenge host factors for survival, for example, Leishmania species utilise host sphingolipid for synthesis of complex sphingolipid. In this study L. mexicana endocytosis was shown to be significantly upregulated in amastigotes, indicating that sphingolipid scavenging may be enhanced. However, inhibition of host sphingolipid biosynthesis had no significant effect on amastigote proliferation within a macrophage cell line. In addition, infection itself did not directly influence host biosynthesis. Notably, in contrast to L. major, L. mexicana amastigotes are indicated to possess a complete biosynthetic pathway suggesting that scavenged sphingolipids may be nonessential for proliferation. This suggested that Old and New World species differ in their interactions with the macrophage host. This will need to be considered when targeting the Leishmania sphingolipid biosynthetic pathway with novel therapeutics

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3177366
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2010). A plate-based assay system for analyses and screening of the Leishmania major inositol phosphorylceramide synthase,”
  2. (2006). Achour-Chenik et al., “Identification of a new developmentally regulated Leishmania major large
  3. (2007). Activation of endocytosis as an adaptation to the mammalianhostbytrypanosomes,”Eukaryotic
  4. (2003). Alvar ,“HIVandthetransmission of Leishmania,”
  5. Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major,”BiochemicalJournal,vol.295,no.2,pp.555–564,1993.
  6. (1994). Complete developmental cycle of Leishmania mexicana in axenic culture,”
  7. (2009). Degradation of host sphingomyelin is essential for Leishmania virulence,”
  8. (1996). Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetiiandChlamydiatrachomatis,”Infection and Immunity,
  9. (2004). e s t e i r o ,G .H .C o o m b s ,a n dJ .C .M o t t r a m ,“ Ap o t e n t i a l role for ICP, a leishmanial inhibitor of cysteine peptidases, in the interaction between host and parasite,”
  10. (1995). eS o u z aL e a o ,T .L a n g ,E .P r i n a ,R .H e l l i o ,a n dJ .C .A n -toine, “Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells,” J o u r n a lo fC e l lS c i e n c e ,
  11. (2011). Exploring Leishmania major Inositol Phosphorylceramide Synthase (LmjIPCS): insights into the ceramide binding domain,”
  12. (1997). Functional rafts in cell membranes,”
  13. (2010). Gel free analysis of the proteomeof intracellular Leishmania mexicana,”
  14. (2001). Generation of ceramide in murine macrophages infected with Leishmania donovanialtersmacrophagesignalingeventsandaidsintracellular parasitic survival,”
  15. (1999). H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L.
  16. (2003). Intracellular parasitism: cell biological adaptations of parasitic protozoa to a life inside cells,”
  17. (2002). Intracellular trafficking of glycosylphosphatidylinositol (GPI)-anchored proteins and free GPIs in Leishmania mexicana,”
  18. (2001). Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages,”
  19. (2002). Leishmania donovani suppresses activated protein 1 and NF-κB activation in hostmacrophagesviaceramidegeneration:involvementofextracellular signal-regulated kinase,”
  20. Leishmania major: clathrin and adaptin complexes of an
  21. (2005). Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis,”MolecularMicrobiology,vol.55,no.5,pp.1566–1578,
  22. (1991). M.J.McConvilleandJ.M.Blackwell,“Developmentalchanges in the glycosylated phosphatidylinositols of Leishmania donovani,”
  23. (1997). N a g i e c ,E .E .N a g i e c ,J .A .B a l t i s b e r g e r
  24. (2008). N.Patel,S.B.Singh,S.K.Basu,andA.Mukhopadhyay,“Leishmania requires Rab7-mediated degradation of endocytosed hemoglobin for their growth,”
  25. (1992). R u s s e l l ,S .X u ,a n dP .C h a k r a b o r t y ,“ I n t r a c e l l u l a rt r a f -ficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages,”
  26. (2008). S.S.S u tt e rwala,F .F .Hs u,E.S.Sev o vaetal.,“Dev elo p me ntall y regulated sphingolipid synthesis in African trypanosomes,”
  27. (2001). Sec r e t o r ya n de n d o c y t i cp a t h w a y sc o n v e r g ei nad y n a m i ce n -d o s o m a ls y s t e mi nap r i m i t i v ep r o t o z o a n ,
  28. (2003). Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism,”
  29. (2000). Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant,”
  30. (2011). Sphingolipid degradation by Leishmania is required for its resistance to acidic pH in the mammalian host,”
  31. (2004). Sphingolipid-free Leishmania are defective in membraneBiochemistry
  32. (2003). Sphingolipids are essential for differentiation but not growth in Leishmania,”
  33. (1992). Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids,”
  34. Studies on the antileishmanial properties of the antimicrobial peptides temporin A, B and 1Sa,” Journal of Peptide Science.
  35. (1998). Subverted transferrin trafficking
  36. (1994). Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid,”
  37. (2002). Tempero et al., “Leishmania RAB7: characterisation of terminal endocytic stages in an intracellular parasite,”
  38. (2002). The endocytic apparatus of the kinetoplastida. Part II: machinery and components of the system,” Trends in Parasitology,
  39. (2002). The kinetoplastida endocytic apparatus. Part I: a dynamic system for nutrition and evasion of host defences,”
  40. (2011). The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis,”
  41. (2006). The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase,”
  42. (2009). The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target,”
  43. (2007). Validation of endogenous reference genes for expression profiling of RAW264.7 cells infected with Mycobacterium avium subsp. paratuberculosis by quantitative